Using high throughput flow cytometry as a versatile tool to identify novel agents modulating immune responses
Stefan Frischbutter, PhD
Wednesday, March 1, 2017
DRFZ: Finding causes – Developing therapies – Improving quality of life
An infrastructure for screening and immunoprofiling of novel drug candidates
Identification of Treg and IL-10 inducing agents: experimental setup
Validation of Treg and IL-10 inducing hits by multi-parameter analysis
Immunmodulation by biological material: Back to nature?!
ImmuDrug - a platform to…
Thank you for your attention!
No transcript for this webinar